GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 751 - 775 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID ▼ Arbitrary Fluorescence Units (AFU)
IgA Patient 1 10 moderate
G81315DD
391
IgA Patient 1 22 moderate
G81315DD
1506
IgA Patient 1 6 moderate
G81315DD
377
IgG Patient 1 10 moderate
G81315DD
33
IgG Patient 1 22 moderate
G81315DD
65
IgM Patient 1 10 moderate
G81315DD
90
IgM Patient 1 22 moderate
G81315DD
364
IgG Patient 1 6 moderate
G81315DD
35
IgM Patient 1 6 moderate
G81315DD
101
IgA Patient 2 15 mild
G81315DD
1098
IgA Patient 2 24 mild
G81315DD
1393
IgG Patient 2 15 mild
G81315DD
107
IgG Patient 2 24 mild
G81315DD
128
IgM Patient 2 15 mild
G81315DD
785
IgM Patient 2 24 mild
G81315DD
974
IgA Patient 2 3 mild
G81315DD
1369
IgG Patient 2 3 mild
G81315DD
148
IgM Patient 2 3 mild
G81315DD
1164
IgA Patient 3 -180 mild
G81315DD
315
IgA Patient 3 11 mild
G81315DD
541
IgG Patient 3 -180 mild
G81315DD
55
IgM Patient 3 -180 mild
G81315DD
182
IgA Patient 3 4 mild
G81315DD
518
IgG Patient 3 11 mild
G81315DD
115
IgG Patient 3 4 mild
G81315DD
90

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024